Breaking News Instant updates and real-time market news.

WVE

Wave Life Sciences

$40.00

-1.35 (-3.26%)

08:17
08/07/18
08/07
08:17
08/07/18
08:17

Wave Life Sciences initiated with a Buy at Stifel

Stifel analyst Paul Matteis initiated Wave Life Sciences (WVE) with a Buy rating and $56 price target, stating that he sees Takeda's (TKPYY) $170M upfront payment as validating to its platform and set of CNS candidates. Wave is one of his favorite names ahead of a catalyst-rich 12-18 months that includes proof-of-concept data in Huntington's in the first half of 2019, and safety and efficacy data for Wave's candidate in Duchenne, Matteis tells investors.

  • 07

    Aug

WVE Wave Life Sciences
$40.00

-1.35 (-3.26%)

03/19/18
MZHO
03/19/18
NO CHANGE
Target $65
MZHO
Buy
Wave Life Sciences price target raised to $65 from $34 at Mizuho
Mizuho analyst Salim Syed raised his price target for Wave Life Sciences to $65 post the company's Q4 results. The analyst keeps a Buy rating on the shares.
06/20/18
LEER
06/20/18
NO CHANGE
Target $55
LEER
Outperform
Micro-dystrophin data raises bar in DMD for Wave Life Sciences, says Leerink
Leerink analyst Geoffrey Porges notes that Sarepta (SRPT) hosted an R&D Day during which it presented data from three patients with Duchenne muscular dystrophy who have received treatment with their micro-dystrophin gene therapy. The results greatly exceeded expectations by demonstrating 38%-54% micro-dystrophin protein expression on Western Blot, he contends. Nonetheless, the analyst points out that he is limited to "patiently awaiting" further results from Sarepta's program in order to determine how exon-skipping oligonucleotides such as Wave Life Sciences' (WVE) WVE-210201 would be positioned in the maintenance post-gene therapy setting, or if the FDA will even accept micro-dystrophin expression as a regulatory endpoint for gene therapy. He reiterates an Outperform rating and $55 price target on Wave's shares.
07/23/18
HCWC
07/23/18
INITIATION
Target $49
HCWC
Buy
Wave Life Sciences assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay assumed coverage of Wave Life Sciences with a Buy rating and $49 price target. The analyst sees "significant upside" for the shares should the company's emerging clinical data hold up to scrutiny.
08/06/18
STFL
08/06/18
INITIATION
STFL
Buy
Wave Life Sciences initiated with a Buy at Stifel

TODAY'S FREE FLY STORIES

TSRO

Tesaro

$37.18

2.22 (6.35%)

13:25
11/19/18
11/19
13:25
11/19/18
13:25
Options
TESARO call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

TRI

Thomson Reuters

$48.53

-0.47 (-0.96%)

13:25
11/19/18
11/19
13:25
11/19/18
13:25
Conference/Events
Thomson Reuters to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/19/18
11/19
13:17
11/19/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/19/18
11/19
13:16
11/19/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$86.70

-2.79 (-3.12%)

13:15
11/19/18
11/19
13:15
11/19/18
13:15
Options
Analog Devices put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

13:10
11/19/18
11/19
13:10
11/19/18
13:10
General news
Euro$ interest rate futures are feeling their oats »

Euro$ interest rate…

BSX

Boston Scientific

$35.50

-1.72 (-4.62%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AA

Alcoa

$33.20

-2.73 (-7.60%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05
Options
Alcoa call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$131.85

-7.7 (-5.52%)

13:04
11/19/18
11/19
13:04
11/19/18
13:04
Periodicals
Instagram is removing inauthentic followers, TechCrunch reports »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LRLCY

L'Oreal

$0.00

(0.00%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03
Hot Stocks
L'Oreal appoints Christophe Babule to succeed Christian Mulliez as CFO »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$37.48

2.52 (7.21%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03
Hot Stocks
Tesaro rallies after canceling appearance at Evercore conference »

Shares of Tesaro are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:56
11/19/18
11/19
12:56
11/19/18
12:56
Hot Stocks
Societe Generale says $1.3B settlement covered by provision for disputes »

Societe Generale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.47

-1.01 (-6.98%)

12:55
11/19/18
11/19
12:55
11/19/18
12:55
Options
Bilibili put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

12:55
11/19/18
11/19
12:55
11/19/18
12:55
General news
Treasury Action: yields rolled over from highs »

Treasury Action: yields…

TWTR

Twitter

$32.25

-1.45 (-4.30%)

12:49
11/19/18
11/19
12:49
11/19/18
12:49
Periodicals
Twitter de-emphasize follower counts in iOS redesign, Verge says »

The follower count on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PBR

Petrobras

$14.60

-0.27 (-1.82%)

12:46
11/19/18
11/19
12:46
11/19/18
12:46
Periodicals
Petrobras' Branco says BR Distribuidora not a natural fit, Reuters says »

Incoming Petrobras CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$114.20

0.35 (0.31%)

12:45
11/19/18
11/19
12:45
11/19/18
12:45
Options
Eli Lilly call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

INGN

Inogen

$137.12

-4.73 (-3.33%)

, RMD

ResMed

$102.53

-1.58 (-1.52%)

12:43
11/19/18
11/19
12:43
11/19/18
12:43
Recommendations
Inogen, ResMed analyst commentary  »

Mobi looks…

INGN

Inogen

$137.12

-4.73 (-3.33%)

RMD

ResMed

$102.53

-1.58 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

MDT

Medtronic

$90.66

-3.02 (-3.22%)

12:35
11/19/18
11/19
12:35
11/19/18
12:35
Options
Medtronic put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:34
11/19/18
11/19
12:34
11/19/18
12:34
Hot Stocks
Societe Generale agrees to pay $1.34B for violations of U.S. sanctions »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

12:30
11/19/18
11/19
12:30
11/19/18
12:30
Periodicals
China's WTO envoy says China to propose WTO changes, Reuters says »

Zhang Xiangchen,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.41

0.11 (0.36%)

12:26
11/19/18
11/19
12:26
11/19/18
12:26
Periodicals
White House still seeking to take Jim Acosta's press pass away, WSJ says »

The White House is still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

PEP

PepsiCo

$118.30

-0.09 (-0.08%)

12:25
11/19/18
11/19
12:25
11/19/18
12:25
Options
PepsiCo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

AAL

American Airlines

$35.36

-1.38 (-3.76%)

12:22
11/19/18
11/19
12:22
11/19/18
12:22
Hot Stocks
APA seeks to open contract negotiations with American Airlines »

The Allied Pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.